Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Androgen Independent Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00174863
What this trial is testing

Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Sanofi 232
Testing effectiveness (Phase 2)Study completedNCT00661492
What this trial is testing

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Who this might be right for
Androgen-independent Prostate Cancer
US Oncology Research 115
Testing effectiveness (Phase 2)Study completedNCT05848011
What this trial is testing

Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Androgen-Independent Prostatic CancerAndrogen-Independent Prostatic NeoplasmsProstate Cancer Recurrent+6 more
MacroGenics 154
Testing effectiveness (Phase 2)Study completedNCT00106418
What this trial is testing

A Research Study for Patients With Prostate Cancer

Who this might be right for
Prostate CancerMetastases
Celgene 35
Testing effectiveness (Phase 2)Study completedNCT00136526
What this trial is testing

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Early research (Phase 1)UnknownNCT00441571
What this trial is testing

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Cytogen Corporation 30
Early research (Phase 1)Study completedNCT00064129
What this trial is testing

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v7
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00081172
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00070837
What this trial is testing

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 46
Testing effectiveness (Phase 2)Ended earlyNCT00471718
What this trial is testing

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Vanderbilt-Ingram Cancer Center 27
Testing effectiveness (Phase 2)Ended earlyNCT00494338
What this trial is testing

Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sanofi 6
Testing effectiveness (Phase 2)Study completedNCT00038246
What this trial is testing

Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00103337
What this trial is testing

Cilengitide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 106
Testing effectiveness (Phase 2)Study completedNCT00350051
What this trial is testing

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

Who this might be right for
Prostate Cancer
Bayer 53
Testing effectiveness (Phase 2)Study completedNCT00964002
What this trial is testing

Efavirenz in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Bergonié 61
Testing effectiveness (Phase 2)Ended earlyNCT00814892
What this trial is testing

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 2